Clinical Trial Update: ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With Asthma

View source ↗

Summary

A completed clinical trial comparing the ELLIPTA dry-powder inhaler with a metered-dose inhaler in adults with asthma to evaluate inhaler preference.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ELLIPTA inhaler

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Status: COMPLETED